178 filings
Page 2 of 9
8-K
2ctiydcq0 v2bjb2p
30 Sep 22
Regulation FD Disclosure
7:58am
8-K
ob6lf bhvwind1vpwx
21 Sep 22
Intercept Pharmaceuticals Announces Summary of Key Actions in Strategic Financial Repositioning
7:30am
8-K
l9r n1b19nd
20 Sep 22
Other Events
4:01pm
8-K
q5f7mo1
12 Sep 22
Entry into a Material Definitive Agreement
7:30am
8-K
0msjs 3yg81s
8 Sep 22
Unregistered Sales of Equity Securities
5:00pm
8-K
0wx0a7v
7 Sep 22
Entry into a Material Definitive Agreement
7:30am
8-K
8ilow om0
6 Sep 22
Unregistered Sales of Equity Securities
5:15pm
8-K
gq7 twanwc05s
2 Sep 22
Entry into a Material Definitive Agreement
7:31am
8-K
vk8qnjs2wlj9q88 74
26 Aug 22
Unregistered Sales of Equity Securities
4:01pm
8-K
1ydmbh
19 Aug 22
Intercept Pharmaceuticals Announces Repurchase of Convertible Notes
7:30am
8-K
0wvk6cgi mk1z4rq2i
16 Aug 22
Other Events
4:01pm
8-K
anwy4i urjfu
3 Aug 22
Intercept Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
7:00am
8-K
jf0vxomf2yeobso
26 Jul 22
Other Events
7:30am
8-K
sha5i0ud
8 Jul 22
Entry into a Material Definitive Agreement
5:29pm
8-K
iypguwavk1l5f7qj04
7 Jul 22
Regulation FD Disclosure
7:30am
8-K
fr4ocw dbfp7cs8olgs
1 Jul 22
Regulation FD Disclosure
4:45pm
8-K
go90rv8p9wezzj99fw5q
21 Jun 22
Other Events
4:02pm
8-K
t1lu2oqe
6 Jun 22
Intercept Provides Update on NASH Regulatory Timeline
6:30am
8-K
evybp 1cph
3 Jun 22
Intercept Announces New Clinical Trial and Real-World Outcomes Data
7:45am
8-K
szq9uvs69f9hdt2li4au
2 Jun 22
Departure of Directors or Certain Officers
4:06pm